Correlation Engine 2.0
Clear Search sequence regions


  • brain (1)
  • child (1)
  • children (1)
  • chir99021 (1)
  • CRMP (1)
  • CRMP2 (5)
  • diseases and (1)
  • fetal growth (1)
  • function later (1)
  • glycogen (2)
  • GSK3β (3)
  • human cell (1)
  • humans (1)
  • neuroblastoma (2)
  • risk diseases (1)
  • signal (3)
  • zinc (12)
  • Sizes of these terms reflect their relevance to your search.

    Previous reports indicated that zinc deficiency could increase the risk of infectious diseases and developmental retardation in children. In experimental study, it has been reported that zinc deficiency during the embryonic period inhibited fetal growth, and disturbed neural differentiation and higher brain function later in adulthood. Although it has been suggested that zinc deficiency during development can have significant effects on neuronal differentiation and maturation, the molecular mechanisms of the effects of low zinc on neuronal differentiation during development have not been elucidated in detail. This study was performed to determine the effects of low zinc status on neurite outgrowth and collapsin response mediator protein 2 (CRMP2) signal pathway. Low zinc suppressed neurite outgrowth, and caused increase levels of phosphorylated CRMP2 (pCRMP2) relative to CRMP2, and decrease levels of phosphorylated glycogen synthase kinase 3β (pGSK3β) relative to GSK3β in human neuroblastoma cell line (SH-SY5Y) cells on days 1, 2, and 3 of neuronal differentiation induction. Neurite outgrowth inhibited by low zinc was restored by treatment with the GSK3β inhibitor CHIR99021. These results suggested that low zinc causes neurite outgrowth inhibition via phosphorylation of CRMP2 by GSK3β. In conclusion, this study is the first to demonstrate that CRMP signaling is involved in the suppression of neurite outgrowth by low zinc.

    Citation

    Hisaka Kurita, Misa Ueda, Miyu Kimura, Ayu Okuda, Kazuki Ohuchi, Isao Hozumi, Masatoshi Inden. Zinc Deficiency Decreases Neurite Extension via CRMP2 Signal Pathway. Biological & pharmaceutical bulletin. 2024;47(4):796-800

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38583951

    View Full Text